Advertisement

Info Diabetologie

, Volume 12, Issue 4, pp 33–47 | Cite as

Schwangerschaft und Stoffwechsel

Kernaspekte der aktualisierten S3-Leitlinie Gestationsdiabetes

  • Jens H. Stupin
zertifizierte fortbildung
  • 474 Downloads

Zusammenfassung

Die Einführung des Screenings auf Gestationsdiabetes mellitus für alle Schwangeren in die Mutterschaftsrichtlinien im Jahr 2012 und ergänzende Studiendaten hatten eine Überarbeitung der entsprechenden Leitlinien in Deutschland notwendig gemacht. Im Folgenden wird ein Überblick über die dort empfohlene Vorgehensweise in Prävention, Screening, Diagnostik, Therapie und Nachsorge des GDM unter Einbeziehung der wesentlichen Neuerungen gegeben.

Literatur

  1. 1.
    Deutsche Diabetes Gesellschaft (DDG), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. 2. Aufl. AWMF-Registernummer: 057/008; 2018. Available from: https://www.awmf.org/uploads/tx_szleitlinien/057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie-Nachsorge_2018-03.pdf [cited 2018-07-01].
  2. 2.
    Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133(Suppl 2):1674S–83S.CrossRefGoogle Scholar
  3. 3.
    Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 1997;20:1717–23.CrossRefGoogle Scholar
  4. 4.
    Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011;18:409–16.CrossRefGoogle Scholar
  5. 5.
    Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knöfler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004;191:2120–4.CrossRefGoogle Scholar
  6. 6.
    Institut für Qualitätssicherung und Transparenz im Gesundheitswesen (IQTiG). Bundesauswertung zum Erfassungsjahr 2016 — Geburtshilfe — Qualitätsindikatoren. Stand: 12.07.2017. Available from: https://iqtig.org/downloads/auswertung/2016/16n1gebh/QSKH_16n1-GEBH_2016_BUAW_V02_2017-07-12.pdf [cited 2018-07-01].Google Scholar
  7. 7.
    Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, Lowe LP, Coustan DR, Hod M, Oats JJ, Persson B, Trimble ER; HAPO Study Cooperative Research Group. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35:526–8.CrossRefGoogle Scholar
  8. 8.
    International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.CrossRefGoogle Scholar
  9. 9.
    Melchior H, Kurch-Bek D, Mund M. The prevalence of gestational diabetes — a population-based analysis of a nationwide screening program. Dtsch Arztebl Int 2017;114:412–8.Google Scholar
  10. 10.
    Teede HJ, Harrison CL, Teh WT, Paul E, Allan CA. Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol 2011;51:499–504.CrossRefGoogle Scholar
  11. 11.
    Pu J, Zhao B, Wang EJ, Nimbal V, Osmundson S, Kunz L, Popat RA, Chung S, Palaniappan LP. Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors. Paediatr Perinat Epidemiol 2015;29:436–43.CrossRefGoogle Scholar
  12. 12.
    Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10:194–203.CrossRefGoogle Scholar
  13. 13.
    Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence—effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 2015;213:310–7.CrossRefGoogle Scholar
  14. 14.
    Zhang MX, Pan GT, Guo JF, Li BY, Qin LQ, Zhang ZL. Vitamin D Deficiency Increases the Risk of Gestational Diabetes Mellitus: A Meta-Analysis of Observational Studies. Nutrients 2015;7:8366–75.CrossRefGoogle Scholar
  15. 15.
    Fadl HE, Ostlund IK, Magnuson AF, Hanson US. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 2010;27:436–41.CrossRefGoogle Scholar
  16. 16.
    Waters TP, Dyer AR, Scholtens DM, Dooley SL, Herer E, Lowe LP, Oats JJ, Persson B, Sacks DA, Metzger BE, Catalano PM; HAPO Cooperative Study Research Group. Maternal and Neonatal Morbidity for Women Who Would Be Added to the Diagnosis of GDM Using IADPSG Criteria: A Secondary Analysis of the Hyperglycemia and Adverse Pregnancy Outcome Study. Diabetes Care 2016;39:2204–2210.CrossRefGoogle Scholar
  17. 17.
    Bhat M, K N R, Sarma SP, Menon S, C V S, S GK. Determinants of gestational diabetes mellitus: A case control study in a district tertiary care hospital in south India. Int J Diabetes Dev Ctries 2010;30:91–6.CrossRefGoogle Scholar
  18. 18.
    Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.CrossRefGoogle Scholar
  19. 19.
    HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.CrossRefGoogle Scholar
  20. 20.
    Martin KE, Grivell RM, Yelland LN, Dodd JM. The influence of maternal BMI and gestational diabetes on pregnancy outcome. Diabetes Res Clin Pract 2015;108:508–13.CrossRefGoogle Scholar
  21. 21.
    Schäfer-Graf UM, Klavehn S, Hartmann R, Kleinwechter H, Demandt N, Sorger M, Kjos SL, Vetter K, Abou-Dakn M. How do we reduce the number of cases of missed postpartum diabetes in women with recent gestational diabetes mellitus? Diabetes Care 2009;32:1960–4.CrossRefGoogle Scholar
  22. 22.
    Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler AG. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792–7.CrossRefGoogle Scholar
  23. 23.
    Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Mølsted-Pedersen L, Hornnes P, Locht H, Pedersen O, Damm P. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004;27:1194–9.CrossRefGoogle Scholar
  24. 24.
    Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773–9.CrossRefGoogle Scholar
  25. 25.
    Akinci B, Celtik A, Yener S, Yesil S. Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 2010;93:1248–54.CrossRefGoogle Scholar
  26. 26.
    Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009;181:371–6.CrossRefGoogle Scholar
  27. 27.
    Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart 2013;99:1118–21.CrossRefGoogle Scholar
  28. 28.
    Kozák-Bárány A, Jokinen E, Kero P, Tuominen J, Rönnemaa T, Välimäki I. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. Early Hum Dev 2004;77:13–22.CrossRefGoogle Scholar
  29. 29.
    Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest 2008;65:227–32.CrossRefGoogle Scholar
  30. 30.
    Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI). S2k-Leitlinie Betreuung von neugeborenen diabetischer Mütter. AWMF-Registernummer: 024/006; 2017. Available from: https://www.awmf.org/uploads/tx_szleitlinien/024-006l_S2k_Betreuung_von_Neugeborenen_diabetischer_Muetter_2017-10.pdf [cited 2018-07-01].
  31. 31.
    Plagemann A, Harder T, Schellong K, Schulz S, Stupin JH. Early postnatal life as a critical time window for determination of long-term metabolic health. Best Pract Res Clin Endocrinol Metab 2012;26:641–53.CrossRefGoogle Scholar
  32. 32.
    Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ; HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012;35:780–6.CrossRefGoogle Scholar
  33. 33.
    Plagemann A. Maternal diabetes and perinatal programming. Early Hum Dev 2011;87:743–7.CrossRefGoogle Scholar
  34. 34.
    Nehring I, Chmitorz A, Reulen H, von Kries R, Ensenauer R. Gestational diabetes predicts the risk of childhood overweight and abdominal circumference independent of maternal obesity. Diabet Med 2013;30:1449–56.CrossRefGoogle Scholar
  35. 35.
    Page KA, Romero A, Buchanan TA, Xiang AH. Gestational diabetes mellitus, maternal obesity, and adiposity in offspring. J Pediatr 2014;164:807–10.CrossRefGoogle Scholar
  36. 36.
    Schaefer-Graf UM, Pawliczak J, Passow D, Hartmann R, Rossi R, Bührer C, Harder T, Plagemann A, Vetter K, Kordonouri O. Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 2005;28:1745–50.CrossRefGoogle Scholar
  37. 37.
    Bider-Canfield Z, Martinez MP, Wang X, Yu W, Bautista MP, Brookey J, Page KA, Buchanan TA, Xiang AH. Maternal obesity, gestational diabetes, breastfeeding and childhood overweight at age 2 years. Pediatr Obes 2017;12:171–178.CrossRefGoogle Scholar
  38. 38.
    Kim SY, England JL, Sharma JA, Njoroge T. Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: a systematic review. Exp Diabetes Res 2011;2011:541308.CrossRefGoogle Scholar
  39. 39.
    Nilsson C, Carlsson A, Landin-Olsson M. Increased risk for overweight among Swedish children born to mothers with gestational diabetes mellitus. Pediatr Diabetes 2014;15:57–66.CrossRefGoogle Scholar
  40. 40.
    Pirkola J, Pouta A, Bloigu A, Hartikainen AL, Laitinen J, Järvelin MR, Vääräsmäki M. Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care 2010;33:1115–21.CrossRefGoogle Scholar
  41. 41.
    Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care 2010;33:964–8.CrossRefGoogle Scholar
  42. 42.
    Landon MB, Rice MM, Varner MW, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Biggio JR Jr, Thorp JM, Chien EK, Saade G, Peaceman AM, Blackwell SC, VanDorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Mild gestational diabetes mellitus and long-term child health. Diabetes Care 2015;38:445–52.CrossRefGoogle Scholar
  43. 43.
    Malcolm JC, Lawson ML, Gaboury I, Lough G, Keely E. Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population. Diabet Med 2006;23:565–70.CrossRefGoogle Scholar
  44. 44.
    Bundesministerium für Gesundheit. Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinien über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung (Mutterschaftsrichtlinien): Einführung eines Screenings auf Gestationsdiabetes. BAnz. Nr. 36, 02.03.2012:914–5.Google Scholar
  45. 45.
    Ryser Rüetschi J, Jornayvaz FR, Rivest R, Huhn EA, Irion O, Boulvain M. Fasting glycaemia to simplify screening for gestational diabetes. BJOG 2016;123:2219–2222.CrossRefGoogle Scholar
  46. 46.
    Johansson K, Cnattingius S, Näslund I, Roos N, Trolle Lagerros Y, Granath F, Stephansson O, Neovius M. Outcomes of pregnancy after bariatric surgery. N Engl J Med 2015;372:814–24.CrossRefGoogle Scholar
  47. 47.
    Syngelaki A, Pastides A, Kotecha R, Wright A, Akolekar R, Nicolaides KH. First-Trimester Screening for Gestational Diabetes Mellitus Based on Maternal Characteristics and History. Fetal Diagn Ther 2015;38:14–21.CrossRefGoogle Scholar
  48. 48.
    D’Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, Larsson L, Lewenstam A, Maas AH, Mager G, Naskalski JW, Okorodudu AO; International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 2005;51:1573–6.CrossRefGoogle Scholar
  49. 49.
    Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE). D-A-CH-Referenzwerte für die Nährstoffzufuhr. 2. Aufl. Neustadt a. d. Weinstraße: Neuer Umschau Buchverlag, 2015.Google Scholar
  50. 50.
    Jovanovic L. Role of diet and insulin treatment of diabetes in pregnancy. Clin Obstet Gynecol 2000;43:46–55.CrossRefGoogle Scholar
  51. 51.
    American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl 1):S61–78.CrossRefGoogle Scholar
  52. 52.
    Hu ZG, Tan RS, Jin D, Li W, Zhou XY. A low glycemic index staple diet reduces postprandial glucose values in Asian women with gestational diabetes mellitus. J Investig Med 2014;62:975–9.CrossRefGoogle Scholar
  53. 53.
    Asemi Z, Tabassi Z, Samimi M, Fahiminejad T, Esmaillzadeh A. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. Br J Nutr 2013; 109:2024–30.CrossRefGoogle Scholar
  54. 54.
    Institute of Medicine (IOM). Weight gain during pregnancy: Reexamining the guidelines. Washington, DC: The National Academies Press 2009.Google Scholar
  55. 55.
    Owe KM, Nystad W, Bø K. Association between regular exercise and excessive newborn birth weight. Obstet Gynecol 2009;114:770–6.CrossRefGoogle Scholar
  56. 56.
    Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.CrossRefGoogle Scholar
  57. 57.
    Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48.CrossRefGoogle Scholar
  58. 58.
    Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ 3rd. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422–7.CrossRefGoogle Scholar
  59. 59.
    Pettitt DJ, Ospina P, Howard C, Zisser H, Jovanovic L. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med 2007;24:1129–35.CrossRefGoogle Scholar
  60. 60.
    Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H; Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186.e1–7.CrossRefGoogle Scholar
  61. 61.
    Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, Damm P, McCance DR; on behalf of the Detemir in Pregnancy Study Group. Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes. Diabetes Care 2012;35:2012–7.CrossRefGoogle Scholar
  62. 62.
    Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet 2015;292:749–56.CrossRefGoogle Scholar
  63. 63.
    Schäfer-Graf UM, Kjos SL, Bühling KJ, Henrich W, Brauer M, Heinze T, Dudenhausen JW, Vetter K. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med 2003;20:349–54.CrossRefGoogle Scholar
  64. 64.
    Balsells M, García-Patterson A, Gich I, Corcoy R. Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: systematic review and meta-analysis. Acta Obstet Gynecol Scand 2014;93:144–51.CrossRefGoogle Scholar
  65. 65.
    Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003–15.CrossRefGoogle Scholar
  66. 66.
    Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011;34:2279–84.CrossRefGoogle Scholar
  67. 67.
    Rowan JA, Rush EC, Plank LD, Lu J, Obolonkin V, Coat S, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care 2018;6:e000456.CrossRefGoogle Scholar
  68. 68.
    Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med 2017;34:27–36.CrossRefGoogle Scholar
  69. 69.
    Kovo M, Haroutiunian S, Feldman N, Hoffman A, Glezerman M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 2008;136:29–33.CrossRefGoogle Scholar
  70. 70.
    Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update 2014;20:656–69.CrossRefGoogle Scholar
  71. 71.
    Tertti K, Eskola E, Rönnemaa T, Haataja L. Neurodevelopment of Two-Year-Old Children Exposed to Metformin and Insulin in Gestational Diabetes Mellitus. J Dev Behav Pediatr 2015;36:752–7.CrossRefGoogle Scholar
  72. 72.
    Wouldes TA, Battin M, Coat S, Rush EC, Hague WM, Rowan JA. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed. 2016 Feb 24.Google Scholar
  73. 73.
    Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 2015;350:h102.CrossRefGoogle Scholar
  74. 74.
    Bauer K, Vetter K, Groneck P, Herting E, Gonser M, Hackelöer BJ, Harms E, Rossi R, Hofmann U, Trieschmann U. Empfehlungen für die strukturellen Voraussetzungen der perinatologischen Versorgung in Deutschland. Z Geburtshilfe Neonatol 2006;210:19–24.CrossRefGoogle Scholar
  75. 75.
    Flores-Le Roux JA, Chillaron JJ, Goday A, Puig De Dou J, Paya A, Lopez-Vilchez MA, Cano JF. Peripartum metabolic control in gestational diabetes. Am J Obstet Gynecol 2010;202:568.e1–6.CrossRefGoogle Scholar
  76. 76.
    Stupin JH. Bedeutung des Stillens für diabetische Mütter und ihre Kinder. Diabetologe 2016;12:13–21.CrossRefGoogle Scholar
  77. 77.
    Petersmann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2018;126:406–410.CrossRefGoogle Scholar
  78. 78.
    Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA 2009;301(8):842–7.CrossRefGoogle Scholar
  79. 79.
    Su X, Zhang Z, Qu X, Tian Y, Zhang G. Hemoglobin A1c for diagnosis of postpartum abnormal glucose tolerance among women with gestational diabetes mellitus: diagnostic meta-analysis. PLoS One 2014;9:e102144.CrossRefGoogle Scholar
  80. 80.
    Benhalima K, Van Crombrugge P, Moyson C et al.. The Sensitivity and Specificity of the Glucose Challenge Test in a Universal Two-Step Screening Strategy for Gestational Diabetes Mellitus Using the 2013 World Health Organization Criteria. Diabetes Care 2018;41:e111–e112.CrossRefGoogle Scholar
  81. 81.
    Metzger BE, Dyer AR. Comment on d’Emden. Do the new threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk? Diabetes Care 2014;37:e30. Diabetes Care 2014;37:e43–4.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für GynäkologieCharité - Universitätsmedizin Berlin, Campus Virchow-KlinikumBerlinDeutschland

Personalised recommendations